| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 02/17/2005 | WO2005014543A1 Condensed ring compound and use thereof as hcv polymerase inhibitor |
| 02/17/2005 | WO2005014529A1 2- adamantyl derivatives as p2x7 receptor antagonists. |
| 02/17/2005 | WO2005013985A1 Treatment for alzheimer's disease and related conditions |
| 02/17/2005 | WO2005013979A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013978A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013977A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013976A1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013975A1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity |
| 02/17/2005 | WO2005013974A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | US20050038261 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition |
| 02/17/2005 | US20050038249 metal complexes used as prodrugs that may be activated under hypoxic conditions by enzymes or by radiotherapy for treatment of cancer |
| 02/17/2005 | US20050038246 PPAR active compounds |
| 02/17/2005 | US20050038212 emulsion; ethylene or other 1-olefins; catalyst complex of nickel or palladium and a salicylaldehyde derivative with an aminopyrrolidine; high activity; highly crystalline polyethylene; narrow molecular weight distribution |
| 02/17/2005 | US20050038114 Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them |
| 02/17/2005 | US20050038101 Substituted 2 5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 02/17/2005 | US20050038097 Modulate and/or inhibit tyrosine kinase signal transduction; antiproliferative agents; treating, prevention of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis |
| 02/17/2005 | US20050038069 Tumor necrosis factor antagonist; antiinflammatory agents; such as 2-Cyclopropyl-4-(3,5-dimethyl-4-pyridylmethoxy)-7-methoxy-3H-benzimidazole |
| 02/17/2005 | US20050038066 Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein tyrosine kinase inhibitors |
| 02/17/2005 | US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 02/17/2005 | US20050038029 Transferring, releasing nitric oxide; side effect reduction; using a compound containing nitrosos group |
| 02/17/2005 | US20050038027 Melanocortin-4 receptor agonists; obesity, type II diabetes; such as N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-(2,6,6-trimethylbicyclo(3.1.1)hept-3yl)piperazine-1-carboximidamide |
| 02/17/2005 | US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 02/17/2005 | US20050038020 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods |
| 02/17/2005 | US20050037383 Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof |
| 02/17/2005 | DE10335450A1 New N-(4-(indoline-1-sulfonyl)-phenyl)-amino acid derivatives, are peroxisome proliferator activated receptor delta activators used e.g. for treating or preventing stroke, arteriosclerosis, coronary heart disease and dyslipidemia |
| 02/17/2005 | DE10335449A1 New 2-((indoline-1-sulfonyl)-tetralinyl or indanyl)-alkanoic acid derivatives, are PPAR-delta activators useful e.g. for treating or preventing stroke, arteriosclerosis, coronary heart disease or dyslipidemia |
| 02/17/2005 | DE10328533A1 New 6-amino-substituted indolinone derivatives, useful e.g. for treating tumours and angiogenesis, are inhibitors of receptor tyrosine kinases |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | CA2534528A1 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparationand use as modulators of apoptosis |
| 02/17/2005 | CA2534240A1 Treatment for alzheimer's disease and related conditions |
| 02/17/2005 | CA2534136A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | CA2534098A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | CA2533996A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 02/17/2005 | CA2533976A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | CA2533970A1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | CA2533433A1 Novel n-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof |
| 02/17/2005 | CA2532351A1 Stable modifications of tegaserod hydrogen maleate |
| 02/16/2005 | EP1506960A1 Indole compounds as inhibitors of tubulin polymerisation for the treatment of angiogenesis-related disorders |
| 02/16/2005 | EP1506777A1 Obesity preventive or ameliorator containing methylidene hydrazide compound as active ingredient |
| 02/16/2005 | EP1506402A2 Bis-transition-metal-chelate-probes |
| 02/16/2005 | EP1506202A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof |
| 02/16/2005 | EP1505966A1 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
| 02/16/2005 | EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 02/16/2005 | EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |
| 02/16/2005 | EP0977545B1 The use of 1-substituted isatins to dye fibers containing keratin |
| 02/16/2005 | CN1582147A Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 02/16/2005 | CN1580044A 7-tert-butoxy-carbonyl-amino-5-azaspiro[2, 4] heptane and its pure stereo-isomer preparing method |
| 02/16/2005 | CN1580037A Symmetrical fluorene derivatives with multi proton absorption |
| 02/16/2005 | CN1189466C New direct chain or cyclic urea, its preparing method and medicinal composition containing them |
| 02/15/2005 | US6855730 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855710 Antiproliferative agents; antitumor agents |
| 02/15/2005 | US6855476 Produce a fluorinated alkyl sulfonic acid having a short perfluoroalkyl chain attached to an ether linkage. This ether linkage connects the fluorinated alkyl portion of the molecule with a variety of other substituents. |
| 02/10/2005 | WO2005012333A2 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 02/10/2005 | WO2005012328A2 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 02/10/2005 | WO2005012291A1 3-amino choman and 2-amino tetralin derivatives |
| 02/10/2005 | WO2005012249A2 Adamantyglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 02/10/2005 | WO2005012244A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 02/10/2005 | WO2005012238A1 Process for the preparation of cpla2 inhibitors |
| 02/10/2005 | WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 02/10/2005 | WO2004110983A3 New benzamides as pparϒ modulators |
| 02/10/2005 | US20050032885 Use as pesticides, microbicides and herbicides; compatible with crop plants |
| 02/10/2005 | US20050032884 Eluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
| 02/10/2005 | US20050032875 Process for the preparation of indole derivatives |
| 02/10/2005 | US20050032874 Indole derivatives |
| 02/10/2005 | US20050032873 3-Amino chroman and 2-amino tetralin derivatives |
| 02/10/2005 | US20050032872 Solvent extraction; slurrying; for production of polymorphs of eletriptan hemisulphate |
| 02/10/2005 | US20050032860 CBI analogs of CC-1065 and the duocarmycins |
| 02/10/2005 | US20050032791 Derivatives of sulphonamides, their preparation and use as medicaments |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050032787 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 02/10/2005 | US20050032747 Cyclooxygenase-2 and Fatty Acid Amide Hydrolase; substituted N-benzoyl-5-((alkyl carbonyl, alkyloxycarbonyl, alkylaminocarbonyl or alkylphosphonato)oxy)indoles; analgesics, antiinflammatory and anxiolytic agents |
| 02/10/2005 | US20050031993 Cyanine compound, optical recording material, and optical recording medium |
| 02/10/2005 | US20050031899 Carbazole derivative, organic semiconductor element, light emitting element, and electronic device |
| 02/10/2005 | US20050031545 Bis-transition-metal-chelate probes |
| 02/10/2005 | US20050031542 using carbocyanine dyes; photodynamic therapy; supplying to tumors |
| 02/10/2005 | CA2534473A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 02/10/2005 | CA2533363A1 3-amino choman and 2-amino tetralin derivatives |
| 02/09/2005 | EP1505125A1 Cyanine compound, optical recording material, and optical recording medium |
| 02/09/2005 | EP1505061A1 Compound exhibiting pgd 2 receptor antagonism |
| 02/09/2005 | EP1504760A1 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy |
| 02/09/2005 | EP1504022A2 Process for the synthesis of peptide amides by side-chain attachment to a solid phase |
| 02/09/2005 | EP1503985A2 Polypeptides and biosynthetic pathways |
| 02/09/2005 | EP1503754A1 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders |
| 02/09/2005 | EP1349839B1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/09/2005 | EP1105376B1 Oxindole derivatives as growth hormone releasers |
| 02/09/2005 | EP1100789B1 Substituted benzoylcyclohexandiones |
| 02/09/2005 | EP1042316B1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188211C Preparation and use of ionic liquids in microwave-assisted chemical transformation |
| 02/08/2005 | US6852751 Difluorobutyric acid metalloprotease inhibitors |
| 02/08/2005 | US6852726 Such as 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)-3-methanesulfonyl-2-methyl-1H-indole for preventing/treating disorders modulated by alpha-1A/L adrenoceptors such as urinary incontinence and sexual disorders |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852716 Central nervous system disorders; psychological disorders |
| 02/08/2005 | US6852711 HIV protease inhibitors |